Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
UNC Molecular Genetics Laboratory, |
RCV001095691 | SCV001251497 | likely pathogenic | USH2A-related disorder | criteria provided, single submitter | research | The USH2A c.3686T>G (p.L1229*) variant is an apparently novel nonsense variant predicted to result in premature protein truncation and/or nonsense-mediated decay. While this particular variant has not been seen previously in affected individuals, other truncating variants are known to be disease-causing with regards to Usher syndrome type 2. | |
Labcorp Genetics |
RCV001231261 | SCV001403776 | pathogenic | not provided | 2023-10-15 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu1229*) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with USH2A-related conditions. ClinVar contains an entry for this variant (Variation ID: 873464). For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV003455444 | SCV004182313 | likely pathogenic | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003455443 | SCV004182314 | likely pathogenic | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003455444 | SCV004206416 | pathogenic | Retinitis pigmentosa 39 | 2022-05-28 | criteria provided, single submitter | clinical testing |